PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

NCT02074436 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Hematological Malignancies
Thrombocytopenia

Interventions

DRUG: EACA
OTHER: Platelet transfusion

Sponsor

Emory University